Litcius/Paper detail

Clinical and preclinical advances in PSMA-Directed Antibody-Drug conjugates (ADCs): Current status and hope for the future

Yousef Mirzaei, Ali Hussein Mer, Bahia Fattah Maran, Leila Omidvar, Fatemeh Misamogooe, Zahra Amirkhani, Nafiseh Javaheri Haghighi, Nader Bagheri, Zahra Keshtkaran, Behzad Rezaei, Farshad Bargrizaneh, Saeed Jahandideh, Nesa Barpour, Hosein Shahsavarani, Ahmadreza Bazyari, Meghdad Abdollahpour‐Alitappeh

2024Bioorganic Chemistry15 citationsDOI

Topics & Concepts

Prostate cancerGlutamate carboxypeptidase IICancer researchAntigenDrugAntibodyCancerClinical trialInternalizationAntibody-drug conjugateMedicinePharmacologyChemistryInternal medicineImmunologyMonoclonal antibodyReceptorProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsMonoclonal and Polyclonal Antibodies Research
Clinical and preclinical advances in PSMA-Directed Antibody-Drug conjugates (ADCs): Current status and hope for the future | Litcius